FDA approves AbbVie’s new drug for advanced Parkinson’s disease
HQ Team October 19, 2024: The U.S. Food and Drug Administration (FDA) has approved AbbVei’s drug Vyalev for the treatment of advanced Parkinson’s.
Drugs
Medical
Pharma